Other highlights in the March 15 JNCI

Dietary Folate Intake Associated with Reduced Pancreatic Cancer Risk

High dietary folate intake may be associated with a reduced risk of pancreatic cancer, a new study suggests. However, supplemental folate intake was not associated with pancreatic cancer risk.

Susanna C. Larsson, M.Sc., of the Karolinska Institute in Stockholm, Sweden, and colleagues gave a food and diet questionnaire to 81,922 cancer-free men and women enrolled in the Swedish Mammography Cohort and Cohort of Swedish Men. They followed these men and women for an average of 6.8 years, and observed 135 cases of pancreatic cancer during that time.

Men and women whose dietary intake of folate was equal to or above 350 micrograms a day had a lower incidence of pancreatic cancer than men and women whose dietary intake of folate was less than 200 micrograms a day. They calculated that there would be 41 cases per 100,000 people who consumed the lowest amounts of folate and 18 cases per 100,000 people among those consuming the most folate. The authors suggest increased dietary folate intake may be associated with a reduced risk of pancreatic cancer.

Contact: Susanna Larsson, Karolinska Institute, 46-8-524-860-59, susanna.larsson@ki.se

Study Examines Childhood Leukemia Incidence and Its Association with Influenza

A new study has found that small peaks in the annual rates of childhood acute lymphoblastic leukemia (ALL) in Britain immediately followed influenza epidemics. The finding supports the hypothesis that some childhood leukemia may be triggered by an infection occurring close to the time of diagnosis.

Mary Kroll, M.Sc., and colleagues at Oxford University, studied time trends of childhood leukemia diagnosed from 1974-2000 in England, Scotland, and Wales, using data from the National Registry of Childhood Tumors.

There was a gradual increase in the incidence of childhood ALL bet

Contact: Ariel Whitworth
Journal of the National Cancer Institute

Page: 1 2 3

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:

(Date:1/7/2019)... ... January 07, 2019 , ... Franz ... Graph Database technology for Knowledge Graphs solutions, announced that it was recognized by ... . DBTA’s data and information management recognition list includes newer approaches leveraging ...
(Date:12/27/2018)... BOSTON (PRWEB) , ... December 27, 2018 , ... ... first 60 cervical discs for implantation at its new Boston facility, and is ... to have additional inventory to immediately expand market share against inferior ball and ...
(Date:12/19/2018)... ... 2018 , ... NDA Partners Chairman Carl Peck, MD, announced today that ... for Devices and Radiological Health (CDRH), has been appointed a Partner in the firm. ... she has more than 25 years of regulatory experience. In addition to her FDA ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/4/2019)... ... January 04, 2019 , ... ... Ted Hoffman to the firm. Ted will be joining the firm as a ... and providing consulting services to the pharmaceutical industry. At Triangle Insights, Ted will ...
(Date:12/19/2018)... ... December 19, 2018 , ... R3 Stem Cell is ... Training Course in Las Vegas. Training includes facial rejuvenation, hair restoration and erectile ... nationwide for aesthetics, having the training from expert, Board Certified providers is critical ...
(Date:12/14/2018)... ... December 14, 2018 , ... NOVA OCULUS ... given the green light to immediately begin a clinical patient trial in Edmonton ... devices bureau of Health Canada has granted what is called an Investigational Testing ...
Breaking Biology Technology:
Cached News: